These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7909714)

  • 1. Changes of plasma concentrations of interleukin-1 alpha and interleukin-6 with neuroleptic treatment for schizophrenia.
    Xu HM; Wei J; Hemmings GP
    Br J Psychiatry; 1994 Feb; 164(2):251-3. PubMed ID: 7909714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokine production in drug-free and neuroleptic-treated schizophrenic patients.
    Bessler H; Levental Z; Karp L; Modai I; Djaldetti M; Weizman A
    Biol Psychiatry; 1995 Sep; 38(5):297-302. PubMed ID: 7495923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum IL-1beta, sIL-2R, IL-6, IL-8 and TNF-alpha in schizophrenic patients, relation with symptomatology and responsiveness to risperidone treatment.
    Erbağci AB; Herken H; Köylüoglu O; Yilmaz N; Tarakçioglu M
    Mediators Inflamm; 2001 Jun; 10(3):109-15. PubMed ID: 11545247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma and cerebrospinal fluid interleukin-1 beta and interleukin-6 in hospitalized schizophrenic patients.
    Katila H; Hurme M; Wahlbeck K; Appelberg B; Rimón R
    Neuropsychobiology; 1994; 30(1):20-3. PubMed ID: 7969854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased interleukin-6 and tumor necrosis factor alpha in first episode schizophrenia patients versus healthy controls.
    Kubistova A; Horacek J; Novak T
    Psychiatr Danub; 2012 Sep; 24 Suppl 1():S153-6. PubMed ID: 22945211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma levels of interleukin-1 beta and interleukin-6 in schizophrenia, other psychoses, and affective disorders.
    Katila H; Appelberg B; Hurme M; Rimón R
    Schizophr Res; 1994 Apr; 12(1):29-34. PubMed ID: 8018583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum cytokine level and production of reactive oxygen species (ROS) by blood neutrophils from a schizophrenic patient with hypersensitivity to neuroleptics.
    Kamińska T; Szuster-Ciesielska A; Wysocka A; Marmurowska-Michałowska H; Dubas-Slemp H; Kandefer-Szerszeń M
    Med Sci Monit; 2003 Jul; 9(7):CS71-5. PubMed ID: 12883457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in interleukin-1 beta and soluble interleukin-2 receptor levels in CSF and serum of schizophrenic patients.
    Barak V; Barak Y; Levine J; Nisman B; Roisman I
    J Basic Clin Physiol Pharmacol; 1995; 6(1):61-9. PubMed ID: 8562579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebrospinal fluid oxytocin concentration in schizophrenic patients does not differ from control subjects and is not changed by neuroleptic medication.
    Glovinsky D; Kalogeras KT; Kirch DG; Suddath R; Wyatt RJ
    Schizophr Res; 1994 Feb; 11(3):273-6. PubMed ID: 7910756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased serum IgE in schizophrenic patients who responded poorly to neuroleptic treatment.
    Ramchand R; Wei J; Ramchand CN; Hemmings GP
    Life Sci; 1994; 54(21):1579-84. PubMed ID: 7910931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma levels of interleukin-6 and tumor necrosis factor alpha in chronic schizophrenia: effects of clozapine treatment.
    Monteleone P; Fabrazzo M; Tortorella A; Maj M
    Psychiatry Res; 1997 Jun; 71(1):11-7. PubMed ID: 9247977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroleptics normalize increased release of interleukin- 1 beta and tumor necrosis factor-alpha from monocytes in schizophrenia.
    Kowalski J; Blada P; Kucia K; Madej A; Herman ZS
    Schizophr Res; 2001 Jul; 50(3):169-75. PubMed ID: 11439237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum levels of soluble IL-2 receptor alpha, IL-6 and IL-1 receptor antagonist in schizophrenia before and during neuroleptic administration.
    Akiyama K
    Schizophr Res; 1999 May; 37(1):97-106. PubMed ID: 10227112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antipsychotic treatment may alter T-helper (TH) 2 arm cytokines.
    Pae CU; Yoon CH; Kim TS; Kim JJ; Park SH; Lee CU; Lee SJ; Lee C; Paik IH
    Int Immunopharmacol; 2006 Apr; 6(4):666-71. PubMed ID: 16504930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-6-(IL-6) plasma levels in depression and schizophrenia: comparison between the acute state and after remission.
    Frommberger UH; Bauer J; Haselbauer P; Fräulin A; Riemann D; Berger M
    Eur Arch Psychiatry Clin Neurosci; 1997; 247(4):228-33. PubMed ID: 9332905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytokine serum levels, autologous mixed lymphocyte reaction and surface marker analysis in never medicated and chronically medicated schizophrenic patients.
    Theodoropoulou S; Spanakos G; Baxevanis CN; Economou M; Gritzapis AD; Papamichail MP; Stefanis CN
    Schizophr Res; 2001 Jan; 47(1):13-25. PubMed ID: 11163541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-2 and interleukin-6 in schizophrenia and mania: effects of neuroleptics and mood stabilizers.
    Maes M; Bosmans E; Calabrese J; Smith R; Meltzer HY
    J Psychiatr Res; 1995; 29(2):141-52. PubMed ID: 7666381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum levels of interleukin-6 and tumor necrosis factor-alpha in exacerbation and remission phase of schizophrenia.
    Dunjic-Kostic B; Jasovic-Gasic M; Ivkovic M; Radonjic NV; Pantovic M; Damjanovic A; Poznanovic ST; Jovanovic A; Nikolic T; Petronijevic ND
    Psychiatr Danub; 2013 Mar; 25(1):55-61. PubMed ID: 23470607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma cytokine response to surgical stress in schizophrenic patients.
    Kudoh A; Sakai T; Ishihara H; Matsuki A
    Clin Exp Immunol; 2001 Jul; 125(1):89-93. PubMed ID: 11472430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytokine production in unmedicated and treated schizophrenic patients.
    Rothermundt M; Arolt V; Leadbeater J; Peters M; Rudolf S; Kirchner H
    Neuroreport; 2000 Oct; 11(15):3385-8. PubMed ID: 11059907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.